U.S. Physical Therapy Inc. (NYSE:USPH) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a note issued to investors on Wednesday.

According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “

Several other brokerages have also recently issued reports on USPH. Jefferies Group set a $65.00 price target on shares of U.S. Physical Therapy and gave the stock a “hold” rating in a research report on Friday, August 5th. Barrington Research cut shares of U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a report on Friday, August 5th. Finally, JMP Securities reaffirmed a “hold” rating on shares of U.S. Physical Therapy in a report on Monday.

Shares of U.S. Physical Therapy (NYSE:USPH) opened at 57.75 on Wednesday. The firm’s 50-day moving average is $60.47 and its 200 day moving average is $59.69. The firm has a market capitalization of $723.09 million, a PE ratio of 29.92 and a beta of 0.85. U.S. Physical Therapy has a 52 week low of $45.62 and a 52 week high of $64.89.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Thursday, November 3rd. The company reported $0.46 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.49 by $0.03. The business had revenue of $88.30 million for the quarter, compared to analyst estimates of $33.94 million. U.S. Physical Therapy had a return on equity of 11.54% and a net margin of 6.84%. The firm’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same period in the prior year, the company posted $0.47 EPS. On average, equities analysts forecast that U.S. Physical Therapy will post $1.93 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 2nd. Investors of record on Friday, November 18th will be issued a $0.17 dividend. The ex-dividend date of this dividend is Wednesday, November 16th. This represents a $0.68 annualized dividend and a yield of 1.18%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 35.05%.

In other U.S. Physical Therapy news, CFO Lawrance W. Mcafee sold 2,000 shares of the stock in a transaction that occurred on Thursday, August 25th. The shares were sold at an average price of $62.50, for a total value of $125,000.00. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Christopher J. Reading sold 8,000 shares of the stock in a transaction that occurred on Monday, September 19th. The shares were sold at an average price of $64.01, for a total transaction of $512,080.00. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by corporate insiders.

Institutional investors have recently made changes to their positions in the stock. Neuberger Berman Group LLC raised its position in shares of U.S. Physical Therapy by 15.2% in the third quarter. Neuberger Berman Group LLC now owns 1,091,731 shares of the company’s stock valued at $68,452,000 after buying an additional 143,834 shares in the last quarter. BlackRock Fund Advisors raised its position in shares of U.S. Physical Therapy by 6.3% in the third quarter. BlackRock Fund Advisors now owns 927,868 shares of the company’s stock worth $58,177,000 after buying an additional 54,747 shares during the period. Vanguard Group Inc. raised its position in shares of U.S. Physical Therapy by 3.3% in the second quarter. Vanguard Group Inc. now owns 577,382 shares of the company’s stock worth $34,765,000 after buying an additional 18,585 shares during the period. Dimensional Fund Advisors LP raised its position in shares of U.S. Physical Therapy by 0.5% in the second quarter. Dimensional Fund Advisors LP now owns 467,348 shares of the company’s stock worth $28,139,000 after buying an additional 2,210 shares during the period. Finally, BlackRock Institutional Trust Company N.A. raised its position in shares of U.S. Physical Therapy by 2.6% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 338,678 shares of the company’s stock worth $21,235,000 after buying an additional 8,478 shares during the period. Institutional investors own 93.51% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

5 Day Chart for NYSE:USPH

Receive News & Stock Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related stocks with our FREE daily email newsletter.